Trial Profile
PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy in Percutaneous Coronary Intervention
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2014
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms PROMISE PCI
- 01 Jul 2014 New trial record